STOCK TITAN

ICU Medical director Finney sells 1,700 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

ICU Medical, Inc. (ICUI) director Elisha W. Finney exercised non-qualified options for 1,700 shares on November 13, 2026, and 65 shares on November 12, at an exercise price of $158.20 per share. He sold the same number of shares on each date at $179 per share. No Rule 10b5-1 plan is reported.

Insider FINNEY ELISHA W
Role Director
Sold 1,765 shs ($316K)
Approx. gross sale proceeds $316K
Approx. exercise cost $279K
Approx. pre-tax spread $37K
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (right to buy) 1,700 $0.00 $0.00
Exercise Common Stock 1,700 $158.20 $269K
Sale Common Stock F1 1,700 $179.00 $304K
Exercise Non-Qualified Stock Option (right to buy) 65 $0.00 $0.00
Exercise Common Stock 65 $158.20 $10K
Sale Common Stock F1 65 $179.00 $12K
Holdings After Transaction: Non-Qualified Stock Option (right to buy) — 0 options (Direct); Common Stock — 4,871 shares (Direct)
Footnotes (1)
  1. F1. All shares sold were sold at the exact price disclosed.
Shares acquired through option exercise 1,700 shares November 13, 2026
Option exercise price $158.20 per share Options exercised November 13, 2026
Shares sold 1,700 shares November 13, 2026
Sale price $179 per share Sale on November 13, 2026
Shares acquired through option exercise 65 shares November 12, 2026
Shares sold 65 shares November 12, 2026
Non-Qualified Stock Option financial
"Non-Qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ICUI shares did Elisha W. Finney sell?

Elisha W. Finney sold 1,700 shares on November 13, 2026, and 65 shares on November 12, at $179 per share on each date. No Rule 10b5-1 plan is reported.

What were Elisha W. Finney’s ICUI option exercise terms?

The non-qualified stock options had an exercise price of $158.20 per share, a reported exercise date of May 9, 2018, and an expiration date of May 9, 2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FINNEY ELISHA W

(Last)(First)(Middle)
951 CALLE AMANECER

(Street)
SAN CLEMENTE CALIFORNIA 92673

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/12/2026M65A$158.24,936D
Common Stock11/12/2026S65D$179(1)4,871D
Common Stock11/13/2026M1,700A$158.26,571D
Common Stock11/13/2026S1,700D$179(1)4,871D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right to buy)$158.211/12/2026M6505/09/201805/09/2027Common Stock65$0.01,700D
Non-Qualified Stock Option (right to buy)$158.211/13/2026M1,70005/09/201805/09/2027Common Stock1,700$0.00D
Explanation of Responses:
1. All shares sold were sold at the exact price disclosed.
By: Paula Darbyshire, Attorney-in-Fact For: Elisha W Finney11/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading